1357.1 - F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for the evaluation of breast cancer

Page last updated: 06 February 2019

Application Detail



Description of Medical Service

The proposed service is 18F-FDG PET scanning for the evaluation of breast cancer in patients who have locally advanced disease where other imaging does not provide sufficient information to determine appropriate treatment and in breast cancer patients where recurrent or metastatic disease is suspected and for whom active therapy is likely to be pursued.

Description of Medical Condition

Breast cancer is the most common cancer in women. In determining the best treatment for each patient, it is important to know when there is locally advanced disease, suspected recurrent breast cancer or metastatic spread. Current diagnostic methods are inferior to PET in evaluation of locally advanced disease, recurrence of disease and identification of metastatic spread. PET provides superior information to guide appropriate medical management.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number


Associated Documentation

Application Form

Application Form (Word 1257 KB)
Application Form (PDF 1766 KB)

PICO Confirmation


Assessment Report


Public Summary Document

Public Summary Document (Word 165 KB)
Public Summary Document (PDF 1301 KB)

Meetings for this Application




5 October 2018


22-23 November 2018